Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Anushka Mukherjee

How Is Kenvue’s Stock Performance Compared to Other Consumer Defensive Stocks

Valued at a market cap of $43.7 billion, New Jersey-based Kenvue Inc. (KVUE) stands as the world’s largest pure-play consumer health company, a testament to over a century of trusted heritage. Its portfolio of iconic brands, such as Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena®, and Tylenol® is rooted in science and trusted by healthcare professionals worldwide. 

Companies worth $10 billion or more are generally described as “large-cap” stocks, and Kenvue fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, stability, and influence in the consumer defensive sector. With a deep belief in the transformative power of everyday care, Kenvue’s mission is to empower consumers to embrace better health and well-being. By delivering products that resonate in hearts and homes globally, Kenvue continues to redefine how care shapes our daily lives.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.